Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a 2023 U.S. NIH grant/contract funding note. It also updates the revision version to v3.6.6, from v3.6.5, indicating updated metadata and documentation.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small metadata change to the page's revision history. This change does not alter the study details or content visible on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page metadata revision was updated from v3.6.3 to v3.6.4. This reflects a new release version of the page's documentation.SummaryDifference0.0%

- Check56 days agoChange DetectedA new site in Vinnytsia, Ukraine (Site 8002) and the associated investigator were added, increasing the total number of locations to 429. The inclusion/eligibility language for KAR-033 was expanded to specify consent procedures, assent, and relocation considerations.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page now displays a new revision label (v3.6.3) replacing the older label (v3.6.1). This indicates a small release update to the page's metadata.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.6.1 replaces v3.6.0 on the page, indicating a small administrative update to the documentation. The substantive content and behavior remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.